Denny Tjiauw Tjoen Lie

Denny Tjiauw Tjoen Lie

Auto-generated profile, based on publicly available information

Denny Tjiauw Tjoen Lie


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Orthopaedics
Verified
Journal Article
Closed access
GYGeraldine Lei Yanlei
Geraldine Lei Yanlei
MKMak Wai Keong
Mak Wai Keong
DTDenny Lie Tijauw Tjoen
Denny Lie Tijauw Tjoen

14 October 2023 in Journal of ISAKOS
Verified
Journal Article
Open access
GZGerald Joseph Zeng
Gerald Joseph Zeng
XSXu Sheng
Xu Sheng
DLDenny Tjiauw Tjoen Lie
Denny Tjiauw Tjoen Lie
Reverse shoulder arthroplasty is typically indicated for patients with severe shoulder osteoarthritis, rotator cuff tear arthropathy, or proximal humerus fractures that have failed to heal properly. The primary goal of reverse shoulder arthroplasty is to improve shoulder function and reduce pain, while also restoring the ability to perform daily activities. There is a growing body of evidence supporting the effectiveness of reverse shoulder arthroplasty in improving shoulder function and reducing pain in patients with severe shoulder osteoarthritis or rotator cuff tear arthropathy. Reverse shoulder arthroplasty is associated with significant improvements in shoulder function and pain reduction compared to non-surgical treatments. This paper aims to summarize current knowledge, practices and present a summary of the long-term effects of reverse shoulder arthroplasty (RSA) on patient outcomes, including how these outcomes are defined and what measures are typically used to assess them. It will also cover newer definitions of outcomes for RSA that have been developed in recent years in order to better understand the long-term effects of the procedure on patient-reported outcomes and functional ability, as well as information on revision surgery and implant survivorship, and the future of RSA (3D-navigation, patient specific instrumentation, robotics and artificial intelligence) and its effects on outcomes.


11 May 2024 in Journal of ISAKOS
Verified
Journal Article
Open access
GZGerald Joseph Zeng
Gerald Joseph Zeng
VMVikaesh Moorthy
Vikaesh Moorthy
YHYing Hao
Ying Hao
DLDenny Tjiauw Tjoen Lie
Denny Tjiauw Tjoen Lie
Patient satisfaction after arthroscopic rotator cuff repair (RCR) is commonly assessed with patient-reported outcome measures (PROMs), and there is an increased need to establish clinical relevance within these measures. The purpose of this study was to (1) define Minimal Clinically Important Difference (MCID), Patient Acceptable Symptomatic State (PASS) and Substantial Clinical Benefit (SCB) for the visual analog scale (VAS) pain score in patients undergoing arthroscopic RCR, and (2) identify preoperative predictors of achieving each of these threshold values. Data from consecutive patients who underwent primary arthroscopic rotator cuff repair study between 2010 and 2016 were prospectively collected. Baseline data and VAS pain scores were collected preoperatively and at 1 year and 2 years postoperatively. MCID, PASS and SCB were determined using an anchor-based approach, with anchor questions assessing postoperative satisfaction and expectation fulfilment. Multivariate logistic regression analysis was also used to identify preoperative predictors for achieving MCID, PASS and SCB. A total of 286 patients were included in the final analysis, with an average age of 60.2 ± 10.4 and the majority being female (61.2%). The values for VAS pain score identified to represent MCID, PASS, and SCB, respectively at 1-year postoperatively were: 5, 2 and 1. The rates of achieving clinically significant improvement based on VAS were 60.5%, 63.3% and 57.2% respectively. A higher preoperative VAS was predictive for achieving MCID (odds ratio [OR], 1.84; P<0.01). This study identified threshold VAS pain scores of 5, 2 and 1 for achieving MCID, PASS, and SCB, respectively, at 1-year follow-up after arthroscopic rotator cuff repair. A higher preoperative VAS pain score was also identified as a statistically significant predictor of attaining MCID after arthroscopic rotator cuff repair. II.

19 April 2023 in Journal of ISAKOS
Verified
Journal Article
Open access
SSShawn J.S. Seah
Shawn J.S. Seah
MYMark H.X. Yeo
Mark H.X. Yeo
CGCheryl Gatot
Cheryl Gatot
DLDenny Lie
Denny Lie
Arthroscopic rotator cuff repairs are known to be associated with substantial pain and post-operative pain management is critical in overall patients' outcomes. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used oral medications and can reduce opioid usage. However, controversies arise due to it postulated effect on postoperative tendon healing. As the evidence of safety and efficacy of NSAIDs remains unclear, this study aims to investigate the effect of NSAIDs on retear rates and clinical outcomes. A systematic search of four databases (PubMed, EMBASE, Scopus and Cochrane Library) was conducted, identifying studies that compared cohorts with post-rotator cuff repair NSAIDs use versus Control groups without NSAID use. Meta-analysis was conducted for Retear rate as well as pain and functional outcomes (Visual analogue scale (VAS) and American Shoulder and Elbow Surgeons Shoulder (ASES) score). Subgroup analysis was conducted for retear rates to determine the overall treatment effect of including selective COX-2 inhibitors. Six studies were included in the meta-analysis. The total baseline cohort size was 916, with 443 (48.3%) patients in the NSAID group and 473 (51.6%) patients in the Control group. There were no statistically significant differences in the baseline characteristics between the two groups. Meta-analysis between the two groups showed that there were no statistically significant differences in Retear rates (p=0.70), early and late post-operative VAS score (p=0.10 and p=0.10 respectively) and latest ASES score (p=0.31). However, subgroup analysis of retear rates revealed a statistically significant difference between the subgroup including COX-2 selective inhibitor versus non-selective COX inhibitor (p<0.01). NSAIDs use in post-arthroscopic rotator cuff repair pain relief does not increase retear rates and can provide similar clinical outcomes compared to a non-NSAID regime. Meta-analysis, level of evidence, 4.

18 June 2024 in Journal of ISAKOS
Verified
Journal Article
Open access
GZGerald Joseph Zeng
Gerald Joseph Zeng
YHYing Hao
Ying Hao
DLDenny Tjiauw Tjoen Lie
Denny Tjiauw Tjoen Lie
There is paucity of literature on the impact of patients' gender on recovery and treatment success after arthroscopic rotator cuff repair. This study investigates the effect of gender on patient-reported outcomes preoperatively and postoperatively (minimum 2 years), and to determine if gender affects attainment of patient acceptable symptomatic state (PASS) thresholds. 266 patients (117 males, 149 female), who underwent primary arthroscopic rotator cuff repair for atraumatic, full-thickness tears, were included. Functional outcomes and pain scores were collected preoperatively and postoperatively. Percentage of attainment of PASS for the various outcome scores was calculated and compared between males and females. Women had statistically significantly poorer functional outcome and pain scores preoperatively and at 1 and 2 years postoperatively (P<0.01). They also experienced less improvement in outcome scores throughout the postoperative period. Women had statistically significantly lower rates of PASS attainment at 2 years postoperatively. Women experience greater pain and poorer shoulder function compared with men preoperatively, and up to 2 years postoperatively. Women are less likely to achieve patient acceptable symptom state thresholds postoperatively, compared to their male counterparts. Retrospective Cohort Study LEVEL OF EVIDENCE: III.